Abstract
Metabolic engineering has been defined as the redirection of metabolic pathways using genetic manipulation. Since the emergence of metabolic engineering science in the early 1980s, the field has made notable strides not only at a conceptual level, but also with regard to translating these concepts into practical products and processes. Today, metabolic engineering plays an important role in the generation of fuels from renewable resources, the conversion of agricultural raw materials (for example, corn syrup) into bulk and specialty chemicals, and the discovery, development and scale-up of therapeutically useful products. This article focuses on recent advances in the last category. Specifically, we review the impact that converging developments in genetic engineering and biosynthetic chemistry are having on natural-product drug discovery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Cragg, G. M., Newman, D. J. & Snader, K. M. Natural products in drug discovery and development. J. Nat. Prod. 60, 52–60 (1997).
McCaskill, D. & Croteau, R. Prospects for the bioengineering of isoprenoid biosynthesis. Adv. Biochem. Eng. Biotechnol. 55, 107–146 (1997).
McCaskill, D. & Croteau, R. Some caveats for bioengineering terpenoid metabolism in plants. Trends Biotechnol. 16, 349–355 (1998).
Fraga, B. M. in Methods in Plant Biochemistry Vol. 7 (eds Charlwood, B. V. & Banthorpe, D. V.) 145–185 (Academic Press, San Diego, 1991).
McGarvey, D. J. & Croteau, R. Terpenoid metabolism. Plant Cell 7, 1015–1026 (1995).
Raskin, I. et al. Plants and human health in the twenty-first century. Trends Biotechnol. 20, 522–531 (2002).
Erkel, G. & Anke, T. Hyphodontal, a new antifungal inhibitor of reverse transcriptases from Hyphodontia sp. (Corticiaceae, Basidomycetes). Z. Naturforsch. [C] 49, 561–570 (1994).
Ferrandiz, M. L. et al. Avarol and avarone, two new anti-inflammatory agents of marine origin. Eur. J. Pharm. 253, 75–82 (1994).
Tan, R. X. et al. Mono- and sesquiterpenes and antifungal constituents from Artemisia species. Planta Med. 65, 64–67 (1999).
Long, B. H. et al. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol). Cancer Res. 58, 1111–1115 (1998).
Hamel, E., Sackett, D. L., Vourloumis, D. & Nicolaou, K. C. The coral-derived natural products eleutherobin and sarcodictyins A and B: effects on the assembly of purified tubulin with and without microtubule-associated proteins and binding at the polymer taxoid site. Biochemistry 38, 5490–5498 (1999).
Nicolaou, K. C. et al. Total synthesis and chemical biology of the sarcodictyins. Chem. Pharm. Bull. (Tokyo) 47, 1199–1213 (1999).
Skeel, R. T. (ed.) Handbook of Chemotherapy 5th edn (Lippincott, Williams & Wilkins, Baltimore, 1999).
Jennewein, S. & Croteau, R. Taxol: biosynthesis, molecular genetics, and biotechnological applications. Appl. Microbiol. Biotechnol. 57, 13–19 (2001).
Gelb, M. H. et al. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett. 91, 169–175 (1995).
Hohl, R. J. Monoterpenes as regulators of malignant cell proliferation. Adv. Exp. Med. Biol. 401, 137–146 (1996).
Gould, M. N. Cancer chemoprevention and therapy by monoterpenes. Environ. Health Perspect. 105, 977–999 (1997).
Eisenreich, W. et al. The deoxyxylulose phosphate pathway of terpenoid biosynthesis in plants and microorganisms. Chem. Biol. 5, R221–R233 (1998).
Lange, B. M., Rujan, T., Martin, W. & Croteau, R. Isoprenoid biosynthesis: the evolution of two ancient and distinct pathways across genomes. Proc. Natl Acad. Sci. USA 97, 13172–13177 (2000).
Steele, C. L., Crock, J., Bohlmann, J. & Croteau, R. Sesquiterpene synthases from grand fir (Abies grandis). Comparison of constitutive and wound-induced activities, and cDNA isolation, characterization, and bacterial expression of δ-selinene synthase and γ-humulene synthase. J. Biol. Chem. 273, 2078–2089 (1998).
Lupien, S., Karp, F., Ponnamperuma, K., Wildung, M. & Croteau, R. Cytochrome P450 limonene hydroxylases of Mentha species. Drug Metab. Drug Interact. 12, 245–260 (1995).
Haudenschild, C., Schalk, M., Karp, F. & Croteau, R. Functional expression of regiospecific cytochrome P450 limonene hydroxylases from mint (Mentha spp.) in Escherichia coli and Saccharomyces cerevisiae. Arch. Biochem. Biophys. 379, 127–136 (2000).
Schalk, M. & Croteau, R. A single amino acid substitution (F363I) converts the regiochemistry of the spearmint (−)-limonene hydroxylase from a C6- to a C3-hydroxylase. Proc. Natl Acad. Sci. USA 97, 11948–11953 (2000).
Wust, M. & Croteau, R. B. Hydroxylation of specifically deuterated limonene enantiomers by cytochrome P450 limonene-6-hydroxylase reveals the mechanism of multiple product formation. Biochemistry 41, 1820–1827 (2002).
Hefner, J. et al. Cytochrome P450-catalyzed hydroxylation of taxa-4(5),11(12)-diene to taxa-4(20),11(12)-dien-5-α-ol: the first oxygenation step in taxol biosynthesis. Chem. Biol. 3, 479–489 (1996).
Schoendorf, A., Rithner, C. D., Williams, R. M. & Croteau, R. B. Molecular cloning of a cytochrome P450 taxane 10β-hydroxylase cDNA from Taxus and functional expression in yeast. Proc. Natl Acad. Sci. USA 98, 1501–1506 (2001).
Walker, K. & Croteau, R. Taxol biosynthetic genes. Phytochemistry 58, 1–7 (2001).
Jennewein, S., Rithner, C. D., Williams, R. M. & Croteau, R. B. Taxol biosynthesis: taxane 13 α-hydroxylase is a cytochrome P450-dependent monooxygenase. Proc. Natl Acad. Sci. USA 98, 13595–13600 (2001).
Walker, K. & Croteau, R. Molecular cloning of a 10-deacetylbaccatin III-10-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli. Proc. Natl Acad. Sci. USA 97, 583–587 (2000).
Walker, K. & Croteau, R. Taxol biosynthesis: molecular cloning of a benzoyl-CoA:taxane 2α-O-benzoyltransferase cDNA from Taxus and functional expression in Escherichia coli. Proc. Natl Acad. Sci. USA 97, 13591–13596 (2000).
Walker, K. et al. Partial purification and characterization of acetyl coenzyme A: Taxa-4(20),11(12)-dien-5α-ol O-acetyl transferase that catalyzes the first acylation step of Taxol biosynthesis. Arch. Biochem. Biophys. 364, 273–279 (1999).
Walker, K., Schoendorf, A. & Croteau, R. Molecular cloning of a taxa-4(20),11(12)-dien-5α-ol-O-acetyl transferase cDNA from Taxus and functional expression in Escherichia coli. Arch. Biochem. Biophys. 374, 371–380 (2000).
Tuveson, R. W., Larson, R. A. & Kagan, J. Role of cloned carotenoid genes expressed in Escherichia coli in protecting against inactivation by near-UV light and specific phototoxic molecules. J. Bacteriol. 170, 4675–4680 (1988).
Chamovitz, D., Misawa, N., Sandmann, G. & Hirschberg, J. Molecular cloning and expression in Escherichia coli of a cyanobacterial gene coding for phytoene synthase, a carotenoid biosynthesis enzyme. FEBS Lett. 296, 305–310 (1992).
Hunter, C. N. et al. Introduction of new carotenoids into the bacterial photosynthetic apparatus by combining the carotenoid biosynthetic pathways of Erwinia herbicola and Rhodobacter sphaeroides. J. Bacteriol. 176, 3692–3697 (1994).
Martinez-Ferez, I., Fernandez-Gonzalez, B., Sandmann, G. & Vioque, A. Cloning and expression in Escherichia coli of the gene coding for phytoene synthase from the cyanobacterium Synechocystis sp. PCC6803. Biochim. Biophys. Acta 1218, 145–152 (1994).
Misawa, H. et al. Expression of a tomato cDNA for phytoene synthase in Escherichia coli, phytoene formation in vivo and in vitro, and functional analysis of the various truncated gene products. J. Biochem. 116, 980–985 (1994).
Yamano, S., Ishii, T., Nakagawa, M., Ikenaga, H. & Misawa, N. Metabolic engineering for production of β-carotene and lycopene in Saccharomyces cerevisiae. Biosci. Biotech. Biochem. 58, 1112–1114 (1994).
Kajiwara, S. et al. Isolation and functional identification of a novel cDNA for astaxanthin biosynthesis from Haematococcus pluvialis, and astaxanthin synthesis in Escherichia coli. Plant Mol. Biol. 29, 343–352 (1995).
Ruther, A., Misawa, N., Boger, P. & Sandmann, G. Production of zeaxanthin in Escherichia coli transformed with different carotenogenic plasmids. Appl. Microbiol. Biotechnol. 48, 162–167 (1997).
Miura, Y. et al. Production of the carotenoids lycopene, β-carotene, and astaxanthin in the food yeast Candida utilis. Appl. Environ. Microbiol. 64, 1226–1229 (1998).
Shimada, H. et al. Increased carotenoid production by the food yeast Candida utilis through metabolic engineering of the isoprenoid pathway. Appl. Environ. Microbiol. 64, 2676–2680 (1998).
Sandmann, G., Albrecht, M., Schnurr, G., Knorzer, O. & Boger, P. The biotechnological potential and design of novel carotenoids by gene combination in Escherichia coli. Trends Biotechnol. 17, 233–237 (1999).
Wang, C. -W., Oh, M. -K. & Liao, J. C. Engineered isoprenoid pathway enhances astaxanthin production in Escherichia coli. Biotechnol. Bioeng. 62, 235–241 (1999).
Martin, V. J. J., Yoshikuni, Y. & Keasling, J. D. The in vivo synthesis of plant sesquiterpenes in Escherichia coli. Biotechnol. Bioeng. 75, 497–503 (2001).
Wang, G. & Keasling, J. D. Amplification of HMG-CoA reductase production enhances carotenoid accumulation in Neurospora crassa. Metab. Eng. 4, 193–201 (2002).
Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D. & Keasling, J. D. Engineering the mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnol. 21, 796–802 (2003).
Cane, D. E., Walsh, C. T. & Khosla, C. Harnessing the biosynthetic code. Combinations, permutations, mutations. Science 282, 63–68 (1998).
Malpartida, F. & Hopwood, D. A. Molecular cloning of the whole biosynthetic pathway of a Streptomyces antibiotic and its expression in a heterologous host. Nature 309, 462–464 (1984).
Santi, D. V., Siani, M. A., Julien, B., Kupfer, D. & Roe, B. An approach for obtaining perfect hybridization probes for unknown polyketide synthase genes: a search for the epothilone gene cluster. Gene 247, 97–102 (2000).
Yadav, G., Gokhale, R. S. & Mohanty, D. SEARCHPKS: a program for detection and analysis of polyketide synthase domains. Nucleic Acids Res. 31, 3654–3658 (2003).
Bentley, S. D. et al. Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature 417, 141–147 (2002).
Kunst, F. et al. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390, 249–256 (1997).
Cole, S. T. et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537–544 (1998).
Minas, W., Brunker, P., Kallio, P. T. & Bailey, J. E. Improved erythromycin production in a genetically engineered industrial strain of Saccharopolyspora erythraea. Biotechnol. Prog. 14, 561–566 (1998).
Askenazi, M. et al. Integrating transcriptional and metabolite profiles to direct the engineering of lovastatin-producing fungal strains. Nature Biotechnol. 21, 150–156 (2003).
Zhang, Y. X. et al. Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature 415, 644–646 (2002).
Pfeifer, B. A. & Khosla, C. Biosynthesis of polyketides in heterologous hosts. Microbiol. Mol. Biol. Rev. 65, 106–118 (2001).
Khosla, C., Gokhale, R., Jacobsen, J. R. & Cane, D. E. Tolerance and specificity of polyketide synthases. Ann. Rev. Biochem. 68, 219–253 (1999).
Gokhale, R. S., Tsuji, S. Y., Cane, D. E. & Khosla, C. Dissecting and exploiting intermodular communication in polyketide synthases. Science 284, 482–485 (1999).
Ranganathan, A. et al. Knowledge-based design of bimodular and trimodular polyketide synthases based on domain and module swaps: a route to simple statin analogues. Chem. Biol. 6, 731–741 (1999).
Stassi, D. L. et al. Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering. Proc. Natl Acad. Sci. USA 95, 7305–7309 (1998).
Jacobsen, J. R., Hutchinson, C. R., Cane, D. E. & Khosla, C. Precursor directed biosynthesis of novel erythromycin analogs by an engineered polyketide synthase. Science 277, 367–369 (1997).
Pacey, M. S. et al. Novel erythromycins from a recombinant Saccharopolyspora erythraea strain NRRL 2338 pIG1. I. Fermentation, isolation and biological activity. J. Antibiot. 51, 1029–1034 (1998).
McDaniel, R. et al. Multiple genetic modifications of the erythromycin polyketide synthase to produce a library of novel unnatural natural products. Proc. Natl Acad. Sci. USA 96, 1846–1851 (1999).
Skatrud, P. L. et al. Use of recombinant DNA to improve production of cephalosporin C by Cephalosporium acremonium. Biotechnology 7, 477–485 (1989).
van de Sandt, E. J. A. X. & de Vroom, E. Inovations in cephalosporin and penicillin production. Painting the antibiotics industry green. Chem. Today 18, 72–75 (2000).
Marahiel, M. A., Stachelhaus, T. & Mootz, H. D. Modular peptide synthetases involved in non-ribosomal peptide synthesis. Chem. Rev. 97, 2651–2674 (1997).
Mootz, H. D., Schwarzer, D. & Marahiel, M. A. Ways of assembling complex natural products on modular nonribosomal peptide synthetases. Chembiochem 3, 490–504 (2002).
Trauger, J. W., Kohli, R. M., Mootz, H. D., Marahiel, M. A. & Walsh, C. T. Peptide cyclization catalysed by the thioesterase domain of tyrocidine synthetase. Nature 407, 215–218 (2000).
Boddy, C. N., Schneider, T. L., Hotta, K., Walsh, C. T. & Khosla, C. Epothilone C macrolactonization and hydrolysis are catalyzed by the isolated thioesterase domain of epothilone polyketide synthase. J. Am. Chem. Soc. 125, 3428–3429 (2003).
Kohli, R. M., Walsh, C. T. & Burkhart, M. D. Biomimetic synthesis and optimization of cyclic peptide antibiotics. Nature 418, 658–661 (2002).
Hugenholtz, J. & Smid, E. J. Nutraceutical production with food-grade microorganisms. Curr. Opin. Biotechnol. 13, 497–507 (2002).
He, X. M. & Liu, H. W. Formation of unusual sugars: mechanistic studies and biosynthetic applications. Annu. Rev. Biochem. 71, 701–754 (2002).
Gaisser, S. et al. Engineered biosynthesis of novel spinosyns bearing altered deoxyhexose substituents. Chem. Comm. 21, 618–619 (2002).
Madduri, K. et al. Production of the antitumor drug epirubicin (4-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Nature Biotechnol. 16, 69–74 (1998).
Rodriguez, L. et al. Engineering deoxysugar biosynthetic pathways from antibiotic-producing microorganisms. A tool to produce novel glycosylated bioactive compounds. Chem. Biol. 9, 721–729 (2002).
Borisova, S. A., Zhao, L., Sherman, D. H. & Liu, H. W. Biosynthesis of desosamine: construction of a new macrolide carrying a genetically designed sugar moiety. Org. Lett. 1, 133–136 (1999).
Hoffmeister, D. et al. Engineered urdamycin glycosyltransferases are broadened and altered in substrate specificity. Chem. Biol. 9, 287–295 (2002).
Losey, H. C. et al. Incorporation of glucose analogs by GtfE and GtfD from the vancomycin biosynthetic pathway to generate variant glycopeptides. Chem. Biol. 9, 1305–1314 (2002).
Tang, L. & McDaniel, R. Construction of desosamine containing polyketide libraries using a glycosyltransferase with broad substrate specificity. Chem. Biol. 8, 547–555 (2001).
Hu, Y. et al. Crystal structure of the MurG:UDP-GlcNAc complex reveals common structural principles of a superfamily of glycosyltransferases. Proc. Natl Acad. Sci. USA 100, 845–849 (2003).
Mulichak, A. M. et al. Structure of the TDP-epi-vancosaminyltransferase GtfA from the chloroeremomycin biosynthetic pathway. Proc. Natl Acad. Sci. USA 100, 9238–9243 (2003).
Acknowledgements
Research in the authors labs has been supported by grants from the National Institutes of Health (to C.K.) and National Science Foundation, Office of Naval Research, Maxygen, Diversa, and the University of California Discovery Grant Program (to J.D.K.).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
Chatian Khosla is a founder of Kosan Biosciences, Inc, which discovers and develops new natural-product drugs. Jay D. Keasling has received funding from Maxygen, Codexis, Inc. and Diversa Corp. for work related to this article.
Related links
Related links
FURTHER INFORMATION
Encyclopedia of Life Sciences
Rights and permissions
About this article
Cite this article
Khosla, C., Keasling, J. Metabolic engineering for drug discovery and development. Nat Rev Drug Discov 2, 1019–1025 (2003). https://doi.org/10.1038/nrd1256
Issue Date:
DOI: https://doi.org/10.1038/nrd1256
This article is cited by
-
Quantitative Methods for Metabolite Analysis in Metabolic Engineering
Biotechnology and Bioprocess Engineering (2023)
-
Debottlenecking the biological hydrogen production pathway of dark fermentation: insight into the impact of strain improvement
Microbial Cell Factories (2022)
-
Deciphering the crucial roles of AraC-type transcriptional regulator Cgl2680 on NADPH metabolism and l-lysine production in Corynebacterium glutamicum
World Journal of Microbiology and Biotechnology (2020)
-
Role of isopentenyl-diphosphate isomerase in heterologous cyanobacterial (Synechocystis) isoprene production
Photosynthesis Research (2016)